Predictmedix AI Inc. (PMED.CN)
| Previous Close | 0.0250 |
| Open | 0.0300 |
| Bid | 0.0250 x N/A |
| Ask | 0.0300 x N/A |
| Day's Range | 0.0250 - 0.0300 |
| 52 Week Range | 0.0250 - 0.1550 |
| Volume | |
| Avg. Volume | 110,619 |
| Market Cap | 4.435M |
| Beta (5Y Monthly) | 1.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | May 29, 2024 - Jun 03, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREPredictmedix AI Expands Strategic Partnerships with Samyak Solutions Inc. and Manchester Marketing Group Inc. for Safe Entry Distribution in the US Market
TORONTO, ON / ACCESSWIRE / March 11, 2024 / Predictmedix Inc. ("Predictmedix" or the "Company") (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today ...
- ACCESSWIRE
Predictmedix AI and UVTV Digital India Forge Strategic Partnership to Revolutionize Health and Safety in Sports and Worship Venues
TORONTO, ON / ACCESSWIRE / February 20, 2024 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix"), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), today ...
- ACCESSWIRE
Predictmedix AI and KGK Science Partner to Enhance Health Research and Product Development
Canadian partnership opens up a new vertical for Predictmedix with significant potential Integration with clinical trials likely to improve efficiency translating into cost savings and ROI for Clinical research organizations TORONTO, ON / ACCESSWIRE ...
